Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combined BVD + IBR + PI3 Inactivated Vaccine
- Development stage
- Preclinical
- Lead developer
- Spirit Jinyu Biological Pharmaceutical
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
This is a trivalent inactivated veterinary vaccine developed by Spirit Jinyu Biological Pharmaceutical for the prevention of respiratory and reproductive diseases in cattle. The vaccine contains inactivated forms of three major viral pathogens: Bovine Viral Diarrhea (BVD) virus, Infectious Bovine Rhinotracheitis (IBR) virus, and Bovine Parainfluenza-3 (PI3) virus. It is designed to induce protective humoral and cellular immunity against these viruses, which are significant contributors to the Bovine Respiratory Disease Complex (BRDC). The product is currently in the IND-enabling and preclinical stages of development.
- Other names
- bovine viral diarrhea inactivated vaccine + bovine infectious rhinotracheitis inactivated vaccine + bovine parainfluenza virus inactivated vaccineCombined Bovine Viral Diarrhea, Bovine Infectious Rhinotracheitis and Bovine Parainfluenza Virus Inactivated VaccineCombined BVD + IBR + PI3 Inactivated Vaccine (Spirit Jinyu)
02
Targets
BPIV-3 (Bovine parainfluenza virus 3)
Beyond the preview
Go deeper on Combined BVD + IBR + PI3 Inactivated Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Combined BVD + IBR + PI3 Inactivated Vaccine.